Skip to main content

Advertisement

Table 1 Clinical features of patients in different MM groups before chemotherapy

From: Variability of serum novel serum peptide biomarkers correlates with the disease states of multiple myeloma

Clinical features ND cases (n = 62) CR&VGPR cases (n = 38) RR cases (n = 43)
Sex
 Male 34 21 27
 Female 28 17 16
Age (year) 56.5 (44–73) 54.5 (44–71) 57.5 (45–73)
WBC (× 109/L) 5.7 (2.7–14) 5.3 (3.2–11.5) 6.2 (2.3–15.3)
Hb (g/L) 83 (52–101) 82 (63–132) 72 (48–95)
PLT (× 109/L) 190 (23–356) 202 (89–387) 183 (56–361)
Subtype
 IgG type 32 20 26
 IgA type 12 8 8
 IgM type 0 0 0
 Light chain type 8 5 5
 Non-secretory type 10 5 4
MM cell > 10% 62 38 43
ESR↑ 53 31 36
Glb (> 30 g/L) 52 33 39
Renal failure (serum creatinine ≥ 2 mg/100 mL) 13 6 9
Hypercalcemia 15 6 8
Bence-Jone protein 21 5 9
LDH↑ 35 19 28
Bone lesions (lytic lesions, pathologic fractures or severe osteopenia) 50 31 35
  1. This table showed clinical features of MM patients in different groups at the time of diagnosis
  2. ESR erythrocyte sedimentation rate, LDH lactate dehydrogenase